Home › Funds › SOMERVILLE KURT F › ABT

SOMERVILLE KURT F position in ABT

ABBOTT LABORATORIES · Health Care

SOMERVILLE KURT F reported holding 76,978 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$7.6M, representing 2.16% of its reported portfolio and ranking #19 among its reported holdings. SOMERVILLE KURT F has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)76.98K sh
Reported value held$7.61M
Portfolio Weight2.16%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SOMERVILLE KURT F's ABT position evolved

SOMERVILLE KURT F first disclosed a stake in ABT in Q3 2023 at 160,479 shares (US$15.5M). The position peaked in Q1 2025 at 162,849 shares, worth US$21.6M. Across 13 filings, SOMERVILLE KURT F increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 76,978 shares valued at US$7.6M — a reduction of -14,975 shares quarter over quarter.. Notable position changes include a 36% trim in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 160.48K $15.54M New
Q4 2023 165.86K $18.26M Add
Q1 2024 165.85K $18.85M Hold
Q2 2024 166.80K $17.33M Add
Q3 2024 165.96K $18.92M Reduce
Q4 2024 166.96K $18.88M Add
Q1 2025 162.85K $21.60M Reduce
Q2 2025 158.66K $21.58M Reduce
Q3 2025 153.51K $20.56M Reduce
Q4 2025 150.84K $18.90M Reduce
Q1 2026 97.08K $9.97M Reduce
Q2 2026 91.95K $8.34M Reduce
Q3 2026 76.98K $7.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has SOMERVILLE KURT F held ABT?

SOMERVILLE KURT F has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SOMERVILLE KURT F's current position in ABT?

As of Q3 2026, SOMERVILLE KURT F holds 76.98K shares of ABT (ABBOTT LABORATORIES), valued at $7.61M, representing 2.16% of its reported portfolio and ranking #19.

Has SOMERVILLE KURT F been buying or selling ABT?

In the latest 13F filing (Q3 2026), SOMERVILLE KURT F reduced its position in ABT. The position peaked in Q1 2025 at 162.85K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.